Can TRT Cause High Hematocrit and AFib? (TRT Q&As)
Timeline
Timestamp
Topic
00:00
How should I manage high hematocrit on TRT after developing AFib?
A 47-year-old man describes hematocrit rising into the mid-50s after starting TRT and then being hospitalized with AFib. Dr. O’Connor discusses testosterone-induced erythrocytosis, phlebotomy, iron studies, sleep apnea, weight, altitude, cardiovascular evaluation, and lowering androgen exposure while emphasizing that the exact relationship between his elevated red blood cells and AFib is uncertain.
A 47-year-old man describes hematocrit rising into the mid-50s after starting TRT and then being hospitalized with AFib. Dr. O’Connor discusses testosterone-induced erythrocytosis, phlebotomy, iron studies, sleep apnea, weight, altitude, cardiovascular evaluation, and lowering androgen exposure while emphasizing that the exact relationship between his elevated red blood cells and AFib is uncertain.
43:00
Why does my blood pressure temporarily rise when I increase my testosterone and Deca doses?
The member notices his blood pressure rises after increasing his androgen doses and then settles back down. Dr. O’Connor explains that anabolic steroids can increase blood pressure through effects on the kidneys, sodium and fluid retention, and the renin-angiotensin-aldosterone system, while warning that the body’s ability to compensate should not be assumed to continue indefinitely.
The member notices his blood pressure rises after increasing his androgen doses and then settles back down. Dr. O’Connor explains that anabolic steroids can increase blood pressure through effects on the kidneys, sodium and fluid retention, and the renin-angiotensin-aldosterone system, while warning that the body’s ability to compensate should not be assumed to continue indefinitely.
48:20
How should I adjust telmisartan when my blood pressure changes with training and steroid doses?
The member asks about using roughly 40 to 50 mg of telmisartan while his blood pressure changes with training and androgen exposure. Dr. O’Connor emphasizes monitoring blood pressure closely and individualizing the medication rather than taking enough to produce symptomatic hypotension, dizziness, or excessively low readings.
The member asks about using roughly 40 to 50 mg of telmisartan while his blood pressure changes with training and androgen exposure. Dr. O’Connor emphasizes monitoring blood pressure closely and individualizing the medication rather than taking enough to produce symptomatic hypotension, dizziness, or excessively low readings.
50:50
Can Masteron cause a major spike in blood pressure?
The member reports blood pressure reaching about 160/100 after using what he believed was Masteron and says it returned toward normal after stopping it. Dr. O’Connor says anabolic steroids can raise blood pressure but also questions whether the underground product was actually Masteron, making its true contents and effects uncertain.
The member reports blood pressure reaching about 160/100 after using what he believed was Masteron and says it returned toward normal after stopping it. Dr. O’Connor says anabolic steroids can raise blood pressure but also questions whether the underground product was actually Masteron, making its true contents and effects uncertain.
55:50
Why did my estradiol increase after I added HCG to my TRT?
A 59-year-old man reports higher estradiol after adding low-dose HCG to testosterone. Dr. O’Connor explains that HCG stimulates the testes and can increase estrogen production, and he questions whether HCG provides enough benefit to justify continuing it when fertility is not the goal and the member feels worse after adding it.
A 59-year-old man reports higher estradiol after adding low-dose HCG to testosterone. Dr. O’Connor explains that HCG stimulates the testes and can increase estrogen production, and he questions whether HCG provides enough benefit to justify continuing it when fertility is not the goal and the member feels worse after adding it.
68:40
At what point should someone on TRT start an aromatase inhibitor?
Dr. O’Connor says he does not favor treating an estradiol number alone and prefers minimizing routine aromatase inhibitor use. When anastrozole is genuinely needed, he discusses using small individualized doses while judging the response by symptoms and follow-up testing because excessive estrogen suppression can negatively affect mood, sexual function, joints, and overall well-being.
Dr. O’Connor says he does not favor treating an estradiol number alone and prefers minimizing routine aromatase inhibitor use. When anastrozole is genuinely needed, he discusses using small individualized doses while judging the response by symptoms and follow-up testing because excessive estrogen suppression can negatively affect mood, sexual function, joints, and overall well-being.
Video Summary
The discussion focuses on situations where testosterone therapy does not produce expected symptom improvement. It emphasizes the importance of evaluating sleep, stress, recovery, and metabolic factors before modifying hormone dosing. Testosterone therapy is framed as one variable within a broader physiologic system.
A central segment examines laboratory interpretation, explaining how timing, assay variation, and biologic adaptation influence results. The episode cautions against repeated dose changes driven by frustration rather than data. Stability and trend analysis are reinforced as essential for clarity.
The closing portion integrates testosterone therapy into comprehensive clinical care. Attention is given to identifying secondary contributors that may blunt response despite adequate hormone levels. Long-term safety and individualized planning are emphasized.
Drug Callouts
Drug
Description
Testosterone
Testosterone is an androgen hormone used therapeutically to treat confirmed testosterone deficiency and related symptoms. In this episode, testosterone therapy is discussed in the context of troubleshooting incomplete symptom response and emphasizing data-driven adjustments.
Condition Callouts
Condition
Description
Sleep deprivation
Sleep deprivation is insufficient or disrupted sleep that impairs endocrine regulation and symptom recovery. It is discussed as a common contributor to poor testosterone therapy response.
Chronic stress
Chronic stress is sustained physiologic stress that alters hormonal signaling and recovery capacity. It is referenced as a factor that can blunt perceived benefits despite adequate testosterone levels.
Key Takeaways
- Persistent symptoms on testosterone therapy often involve non-hormonal contributors.
- Sleep and stress strongly influence perceived treatment response.
- Laboratory trends are more informative than isolated values.
- Repeated dose escalation can obscure true causes of symptoms.
- Comprehensive evaluation supports safer long-term hormone management.